136 related articles for article (PubMed ID: 10343374)
1. A study of the aetiology of pseudopregnancy in the bitch and the effect of cabergoline therapy.
Harvey MJ; Dale MJ; Lindley S; Waterston MM
Vet Rec; 1999 Apr; 144(16):433-6. PubMed ID: 10343374
[TBL] [Abstract][Full Text] [Related]
2. Effect and mechanisms of the anti-prolactin drug cabergoline on pseudopregnancy in the bitch.
Harvey MJ; Cauvin A; Dale M; Lindley S; Ballabio R
J Small Anim Pract; 1997 Aug; 38(8):336-9. PubMed ID: 9282338
[TBL] [Abstract][Full Text] [Related]
3. Study of the change of prolactin and progesterone during dopaminergic agonist treatments in pseudopregnant bitches.
Gobello C; de la Sota RL; Goya RG
Anim Reprod Sci; 2001 May; 66(3-4):257-67. PubMed ID: 11348786
[TBL] [Abstract][Full Text] [Related]
4. Effects on pseudopregnancy, pregnancy and interoestrous intervals of pharmacological suppression of prolactin secretion in female dogs and cats.
Jöchle W; Arbeiter K; Post K; Ballabio R; D'Ver AS
J Reprod Fertil Suppl; 1989; 39():199-207. PubMed ID: 2621723
[TBL] [Abstract][Full Text] [Related]
5. Coat colour changes associated with cabergoline administration in bitches.
Gobello C; Castex G; Broglia G; Corrada Y
J Small Anim Pract; 2003 Aug; 44(8):352-4. PubMed ID: 12934808
[TBL] [Abstract][Full Text] [Related]
6. Canine pseudopregnancy: an evaluation of prevalence and current treatment protocols in the UK.
Root AL; Parkin TD; Hutchison P; Warnes C; Yam PS
BMC Vet Res; 2018 May; 14(1):170. PubMed ID: 29793494
[TBL] [Abstract][Full Text] [Related]
7. Treatment of lactating sows with the dopamine agonist Cabergoline: effects on LH and prolactin secretion and responses to challenges with naloxone and morphine.
De Rensis F; Quintavalla F; Foxcroft GR
Anim Reprod Sci; 1998 May; 51(3):233-47. PubMed ID: 9675405
[TBL] [Abstract][Full Text] [Related]
8. Effect of stage of anestrus on the induction of estrus by the dopamine agonist cabergoline in dogs.
Verstegen JP; Onclin K; Silva LD; Concannon PW
Theriogenology; 1999 Feb; 51(3):597-611. PubMed ID: 10729045
[TBL] [Abstract][Full Text] [Related]
9. Effect of an injectable cabergoline formulation on serum prolactin (PRL) and milk secretion in early postpartum Beagle bitches.
Romagnoli S; Milani C; Perin S; Ballabio R; Stelletta C; Mollo A; Gelli D
Reprod Domest Anim; 2009 Jul; 44 Suppl 2():148-51. PubMed ID: 19754555
[TBL] [Abstract][Full Text] [Related]
10. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
Rains CP; Bryson HM; Fitton A
Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
[TBL] [Abstract][Full Text] [Related]
11. Follicular development and plasma concentrations of LH and prolactin in anestrous female dogs treated with the dopamine agonist cabergoline.
Spattini G; Borghi V; Thuróczy J; Balogh L; Scaramuzzi RJ; De Rensis F
Theriogenology; 2007 Oct; 68(6):826-33. PubMed ID: 17689603
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations of prolactin in overtly pseudopregnant Afghan hounds and the effect of metergoline.
Okkens AC; Dieleman SJ; Kooistra HS; Bevers MM
J Reprod Fertil Suppl; 1997; 51():295-301. PubMed ID: 9404298
[TBL] [Abstract][Full Text] [Related]
13. [Plasma prolactin concentration and the effect of metergoline in pseudopregnant Afghan hounds].
Okkens AC; Dieleman SJ; Kooistra HS; Bevers MM
Tijdschr Diergeneeskd; 2000 Feb; 125(3):81-5. PubMed ID: 10680206
[TBL] [Abstract][Full Text] [Related]
14. Selective control of the estrous cycle of the dog through suppression of estrus and reduction of the length of anestrus.
Phillips TC; Larsen RE; Hernandez J; Strachan L; Samuelson D; Shille VM; Archbald LF
Theriogenology; 2003 Mar; 59(5-6):1441-8. PubMed ID: 12527090
[TBL] [Abstract][Full Text] [Related]
15. Modulatory effect of vitamin B6 on sex hormone receptors, thyroid, and kisspeptin/kiss1r system in the uterus of pseudopregnant bitches.
Santos LC; Santana LR; Niella RV; Machado WM; Silva JF; Snoeck PPDN
Reprod Domest Anim; 2024 Jun; 59(6):e14630. PubMed ID: 38847348
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of cabergoline on rapid escalation of dose in men with macroprolactinomas.
Bhansali A; Walia R; Dutta P; Khandelwal N; Sialy R; Bhadada S
Indian J Med Res; 2010 Apr; 131():530-5. PubMed ID: 20424304
[TBL] [Abstract][Full Text] [Related]
17. Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels.
Krysiak R; Okopien B
Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):251-6. PubMed ID: 25123447
[TBL] [Abstract][Full Text] [Related]
18. Termination of dioestrus and induction of oestrus in dioestrous nonpregnant bitches by the prolactin antagonist cabergoline.
Jeukenne P; Verstegen J
J Reprod Fertil Suppl; 1997; 51():59-66. PubMed ID: 9404272
[TBL] [Abstract][Full Text] [Related]
19. New hyperprolactinemia and anovulation model in common marmoset (Callithrix jacchus) and effect of cabergoline.
Moro M; Inada Y; Kojima M; Miyata H; Komatsu H; Torii R
Eur J Pharmacol; 1999 Feb; 368(1):57-66. PubMed ID: 10096770
[TBL] [Abstract][Full Text] [Related]
20. [Cabergoline in the inhibition of lactogenesis and suppression of lactopoiesis].
Bracco PL; Armentano G; Pellegrini A; Sugliano GC; Tornatore GP
Minerva Ginecol; 1997 Oct; 49(10):469-73. PubMed ID: 9463181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
